openPR Logo
Press release

Prevalence of Complicated Urinary Tract Infection (UTI) to Increase Globally

05-09-2017 02:58 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Future Market Insights

Prevalence of Complicated Urinary Tract Infection (UTI)

Over 60% physicians are likely to prescribe penicillin and combinations to treat urinary tract infections (UTIs), whereas a vast majority prescribe quinolones in their daily practice to treat complicated cases. A significant percentage of physicians also agreed that they prescribed nitrofurans to treat uncomplicated urinary tract infections in female patients. FMI’s survey also found that cephalosporin is the second-most common drug in the treatment of recurrent and complicated urinary tract infections.

Prevalence of urinary tract infections is higher in females as compared to males, with biologic and behavioural factors accounting for the major causes. Development of this ailment due to genetic causes or urogenital surgery and Estrogen deficiency was minimal.

FMI’s survey also found that prevalence of uncomplicated URI was significantly higher than complicated-, recurring complicated UTIs. However, prevalence of complicated UTI is expected to increase in the future, owing to increase in drug-resistant bacteria and excessive use of antibiotics.

The global urinary tract infection treatment market is expected to reach US$ 9.42 Bn in revenues. Complex regulatory requirements and low investment in research and development are some of the key factors for sluggish growth of the market. Clinical trials for designing antibacterial drugs are quite complex, owing to which a number of major companies have decreased their R&D spending on the development of new drugs. Moreover, UTI are not chronic like blood pressure or heart diseases and patients are symptom-free usually within 1-2 weeks of treatment, resulting into limited sales of the drugs. In addition to these factors, economic and regulatory hurdles are also restraining the growth of the urinary tract infection treatment market.

Request For Report Sample: http://www.futuremarketinsights.com/reports/sample/rep-gb-1340

By drug type, quinolones account for the highest revenue share of the global urinary tract infection treatment market. This segment is expected to account for nearly 37.2% share of the global urinary tract infection treatment market revenues in 2016. This represents a market value of nearly US$ 3.5 Bn, up from US$ 3.43 Bn in 2015. Among quinolones, levofloxacin is the most sought-after drug type, representing nearly US$ 1.59 Bn in revenues in 2015. Penicillin and combinations is the second largest drug type, and is expected to total US$ 1.87 Bn in revenues.

Retail pharmacies will continue to remain the largest segment in terms of distribution channel in 2016. This segment accounts for nearly 56.8% revenue share, representing a market value of US$ 5.35 Bn. Gynaecology and urology clinics collectively is the second largest segment by distribution channel.

By disease indication, uncomplicated UTI will continue to dominate global revenues. This segment currently accounts for a revenue share of 52.7%, representing a market value of US$ 4.96 Bn in 2016. Neurogenic bladder infections, the second-largest segment by disease indication, is expected to increase by 2.30% in 2016.

Send An Enquiry: http://www.futuremarketinsights.com/askus/rep-gb-1340

Asia Pacific excluding Japan (APEJ) will continue to be the leading market for urinary tract infections, with total revenues expected to reach US$ 3.46 Bn in 2016. Western Europe and North America will remain the second and third largest markets respectively.

Key players operating in the urinary tract infection treatment market include Johnson & Johnson, Boehringer Ingelheim, Cipla Ltd., Bayer AG, GSK, Roche Ltd., Pfizer Inc., Novartis AG, and AstraZeneca plc. The key strategy of a majority of these key players is to expand in emerging markets and achieving inorganic growth through mergers and acquisitions.

Long-term Outlook: The global urinary tract infection treatment market is anticipated to increase at a CAGR of 2.1% during the forecast period 2016-2026 and reach US$ 11.58 Bn in revenues.

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

CONTACT:
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Website: http://www.futuremarketinsights.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Prevalence of Complicated Urinary Tract Infection (UTI) to Increase Globally here

News-ID: 529060 • Views: 213

More Releases from Future Market Insights

Corn Co-Products Market by Services, Company Profiling, Business Revenue, and Gr …
The report covers various factors affecting the Corn Co-Products market. FMI provides in-depth insights into the market. It presents the study in a coherent chapter-wise format, interspersed with data and relevant infographics. The report adopts an analytical approach to help our clients get better understanding about the market. Our expert market research analysts in the food & beverage industry domain carries out an extensive primary and secondary research with the
Lemon Juice Concentrate Market by Competitive Landscape, SWOT Analysis, Opportun …
The report covers various factors affecting the Lemon Juice Concentrate Market. FMI provides in-depth insights into the market. It presents the study in a coherent chapter-wise format, interspersed with data and relevant infographics. The report adopts an analytical approach to help our clients get better understanding about the market. Our expert market research analysts in the food & beverage industry domain carries out an extensive primary and secondary research with
Slimming Tea Market | Where Should Participant Focus To Gain Maximum ROI | Exclu …
The report covers various factors affecting the Slimming Tea market. FMI provides in-depth insights into the market. It presents the study in a coherent chapter-wise format, interspersed with data and relevant infographics. The report adopts an analytical approach to help our clients get a better understanding of the market. Our expert market research analysts in the food & beverage industry domain carry out extensive primary and secondary research with the
A New FMI Study Analyses Growth of Citrus Pulp Fiber Market in Light of the Glob …
Increased consumer understanding of food safety has contributed to the use of important ingredients, such as citrus pulp fiber, which are vital to control body metabolism and digestion. With the advent of a clean label campaign, the market for safe and nutritious food products has expanded and the incorporation of citrus pulp fiber in the food and beverage industry has increased across a variety of product offerings. According to the World

All 5 Releases


More Releases for UTI

Logistic Software Market Will Hit Big Revenues In Future | Oracle, UTi Worldwide …
Latest released the research study on Global Logistic Software Market, offers a detailed overview of the factors influencing the global business scope. Logistic Software Market research report shows the latest market insights; current situation analysis with upcoming trends and breakdown of the products and services. The report provides key statistics on the market status, size, share, growth factors of the Logistic Software. The study covers emerging player’s data, including: competitive
Consumer Packaged Goods (CPG) Logistics Market Is Booming Worldwide | FedEx, UTi …
HTF Market Intelligence released a new research report of 80 pages on title 'Global Consumer Packaged Goods (CPG) Logistics Market Size study, by Component (Transportation, Warehousing, Value-Added Services), by Application (Food & Beverages Sector, Footwear and Apparel Sector, Tobacco Sector, Cleaning Products Sector, Others) and by Regional Forecasts 2018-2025' with detailed analysis, forecast and strategies. The study covers key regions that includes Asia Pacific, North America, Europe, Latin America and
UTI Treatment Market Therapeutic Assessment 2018-2023
Global and Chinese UTI Treatment Industry, 2018 Market Research Report: The 'Global and Chinese UTI Treatment Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global UTI Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the UTI Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals
Global X-Ray Screening Systems Market Research Report 2018 : ADANI, Scanna, UTI …
Qyresearchreports include new market research report "Global X-Ray Screening Systems Market Research Report 2018" to its huge collection of research reports. The general X-Ray Screening Systems market has been seen on a couple of perspectives that are inside and out that truly matters there, and have repaired the market circumstance to the mammoth degree. The report in like way indicates unmistakable experience and information related to general X-Ray Screening Systems market.
UTI treatment Business Trends That Will Drive Success In 2023
The Global UTI treatment Market is growing with the rapid pace; mainly due the burgeoning Healthcare Sector. According to a recent study report published by the Market Research Future, The global UTI treatment Market is booming and expected to gain prominence over the forecast period. Global UTI treatment Market Information; by Drug Class (Quinolones, Aminoglycosides, β-lactam, Azoles and Others), by Clinical Indications (Urethritis, Cystitis, Pyelonephritis), by End User (Hospitals and Self-administered)
Prevalence of Complicated Urinary Tract Infection (UTI) to Increase Globally
Over 60% physicians are likely to prescribe penicillin and combinations to treat urinary tract infections (UTIs), whereas a vast majority prescribe quinolones in their daily practice to treat complicated cases. A significant percentage of physicians also agreed that they prescribed nitrofurans to treat uncomplicated urinary tract infections in female patients. FMI’s survey also found that cephalosporin is the second-most common drug in the treatment of recurrent and complicated urinary tract